Publikationen von Larysa Teplytska

Filiou, M. D.; Teplytska, L.; Nussbaumer, M.; Otte, D.-M.; Zimmer, A.; Turck, C. W.: Multi-Omics Analysis Reveals Myelin, Presynaptic and Nicotinate Alterations in the Hippocampus of G72/G30 Transgenic Mice. JOURNAL OF PERSONALIZED MEDICINE 12 (2), 244 (2022)

Filiou, M. D.; Nussbaumer, M.; Teplytska, L.; Turck, C. W.: Y Behavioral and Metabolome Differences between C57BL/6 and DBA/2 Mouse Strains: Implications for Their Use as Models for Depression- and Anxiety-Like Phenotypes. METABOLITES 11 (2), 128 (2021)

Lopes, S.; Teplytska, L.; Vaz-Silva, J.; Dioli, C.; Trindade, R.; Morais, M.; Webhofer, C.; Maccarrone, G.; Almeida, O. F. X.; Turck, C. W. et al.; Sousa, N.; Sotiropoulos, I.; Filiou, M. D.: Tau Deletion Prevents Stress-Induced Dendritic Atrophy in Prefrontal Cortex: Role of Synaptic Mitochondria. CEREBRAL CORTEX 27 (4), S. 2580 - 2591 (2017)

Weckmann, K.; Deery, M. J.; Howard, J. A.; Feret, R.; Asara, J. M.; Dethloff, F.; Filiou, M. D.; Iannace, J.; Labermaier, C.; Maccarrone, G. et al.; Webhofer, C.; Teplytska, L.; Lilley, K.; Mueller, M. B.; Turck, C. W.: Ketamine's antidepressant effect is mediated by energy metabolism and antioxidant defense system. SCIENTIFIC REPORTS 7, 15788 (2017)

Nussbaumer, M.; Asara, J. M.; Teplytska, L.; Murphy, M. P.; Logan, A.; Turck, C. W.; Filiou, M. D.: Selective Mitochondrial Targeting Exerts Anxiolytic Effects In Vivo. NEUROPSYCHOPHARMACOLOGY 41 (7), S. 1751 - 1758 (2016)

Turck, C. W.; Webhofer, C.; Nussbaumer, M.; Teplytska, L.; Chen, A.; Maccarrone, G.; Filiou, M. D.: Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. Proteomics. Clinical applications 10 (12), S. 1269 - 1272 (2016)

Turck, C. W.; Webhofer, C.; Nussbaumer, M.; Teplytska, L.; Chen, A.; Maccarrone, G.; Filiou, M. D.: Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. SI 10 (12), S. 1269 - 1272 (2016)

Filiou, M. D.; Asara, J. M.; Nussbaumer, M.; Teplytska, L.; Landgraf, R.; Turck, C. W.: Behavioral extremes of trait anxiety in mice are characterized by distinct metabolic profiles. JOURNAL OF PSYCHIATRIC RESEARCH 58, S. 115 - 122 (2014)

Filiou, M. D.; Teplytska, L.; Otte, D. M.; Zimmer, A.; Turck, C. W.: Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model. Journal of Psychiatric Research 46 (10), S. 1359 - 1365 (2012)

Ditzen, C.; Tang, N.; Jastorff, A. M.; Teplytska, L.; Yassouridis, A.; Maccarrone, G.; Uhr, M.; Bronisch, T.; Miller, C. A.; Holsboer, F. et al.; Turck, C. W.: Cerebrospinal Fluid Biomarkers for Major Depression Confirm Relevance of Associated Pathophysiology. Neuropsychopharmacology 37 (4), S. 1013 - 1025 (2012)

Filiou, M. D.; Zhang, Y. Y.; Teplytska, L.; Reckow, S.; Gormanns, P.; Maccarrone, G.; Frank, E.; Kessler, M. S.; Hambsch, B.; Nussbaumer, M. et al.; Bunck, M.; Ludwig, T.; Yassouridis, A.; Holsboer, F.; Landgraf, R.; Turck, C. W.: Proteomics and Metabolomics Analysis of a Trait Anxiety Mouse Model Reveals Divergent Mitochondrial Pathways. Biological Psychiatry 70 (11), S. 1074 - 1082 (2011)

Filiou, M. D.; Teplytska, L.; Gormanns, P.; Reckow, S.; Zhang, Y.; Frank, E.; Kessler, M. S.; Nussbaumer, M.; Maccarrone, G.; Landgraf, R. et al.; Turck, C. W.: Anxiety and mitochondria: Insights from the -omics world. Pharmacopsychiatry 44 (6), S. 289 - 289 (2011)

Filiou, M. D.; Teplytska, L.; Otte, D. M.; Yilmaz, O.; Zimmer, A.; Turck, C. W.: Proteomic alterations in G72/G30 transgenic mice. Pharmacopsychiatry 44 (6), S. 289 - 289 (2011)

Ditzen, C.; Varadarajulu, J.; Czibere, L.; Gonik, M.; Targosz, B. S.; Hambsch, B.; Bettecken, T.; Kessler, M. S.; Frank, E.; Bunck, M. et al.; Teplytska, L.; Erhardt, A.; Holsboer, F.; Mueller-Myhsok, B.; Landgraf, R.; Turck, C. W.: Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathways. Molecular Psychiatry 15 (7), S. 702 - 711 (2010)

Filiou, M. D.; Bisle, B.; Reckow, S.; Teplytska, L.; Maccarrone, G.; Turck, C. W.: Profiling of mouse synaptosome proteome and phosphoproteome by IEF. Electrophoresis 31 (8), S. 1294 - 1301 (2010)

Ditzen, C.; Varadarajulu, J.; Czibere, L.; Gonik, M.; Bunck, M.; Teplytska, L.; Müller-Myhsok, B.; Holsboer, F.; Landgraf, R.; Turck, C. W.: Proteomic genotyping in a mouse model of trait anxiety exposes disease relevant pathways. Pharmacopsychiatry 42 (5), S. 215 - 216 (2009)

Filiou, M. D.; Zhang, Y. Y.; Bisle, B.; Frank, E.; Kessler, M. S.; Teplytska, L.; Reckow, S.; Haegler, K.; Maccarrone, G.; Hambsch, B. et al.; Landgraf, R.; Turck, C. W.: Stable isotope metabolic labeling of a mouse model reveals synaptic biomarkers for anxiety disorders. Pharmacopsychiatry 42 (5), S. 217 - 217 (2009)

Ditzen, C.; Jastorff, A. M.; Kessler, M. S.; Bunck, M.; Teplytska, L.; Erhardt, A.; Krömer, S. A.; Varadarajulu, J.; Targosz, B. S.; Sayan-Ayata, E. F. et al.; Holsboer, F.; Landgraf, R.; Turck, C. W.: Protein biomarkers in a mouse model of extremes in trait anxiety. Molecular & Cellular Proteomics 5 (10), S. 1914 - 1920 (2006)

Maccarrone, G.; Kolb, N.; Teplytska, L.; Birg, I.; Zollinger, R.; Holsboer, F.; Turck, C. W.: Phosphopeptide enrichments by IEF. Electrophoresis 27, S. 4585 - 4595 (2006)

Turck, C. W.; Maccarrone, G.; Sayan-Ayata, E.; Jacob, A. M.; Ditzen, C.; Kronsbein, H.; Birg, I.; Doertbudak, C.-C.; Haegler, K.; Lebar, M. et al.; Teplytska, L.; Kolb, N.; Uwaje, N.; Zollinger, R.: The quest for brain disorder biomarkers. The Journal of Medical Investigation 52 (Supplement), S. 231 - 235 (2005)